Tennessee's CoverRX program stops enrollment due to high demand

Enrollment has been suspended for CoverRX, Tennessee's new prescription drug program for low-income adults, as a result of high demand, the Tennessean reports.

As of Feb. 8, nearly 21,000 people were enrolled in the program, which provides prescription drug coverage for uninsured individuals or for those who have insurance that does not cover medication.

About 2,500 applications have been frozen, and about 1,000 new applications are being submitted each week, according to officials.

The program is part of Gov. Phil Bredesen's (D) Cover Tennessee health initiative, which includes three health insurance plans to provide coverage for children, low-income working adults and those with pre-existing medical conditions.

CoverRX was expected to provide drug coverage to between 25,000 to 50,000 people in fiscal year 2007, and $11.5 million has been budgeted for the program this fiscal year.

CoverRX program director Kendra Gipson said of the enrollment freeze, "We have a certain amount of funding we have to work with," adding, "We want to watch utilization carefully."

State officials said residents still can submit applications, and officials will evaluate whether to reopen enrollment in late March.

Gipson said, "If we can support more people in the future, we will," noting space might open in the program if some CoverRX beneficiaries are accepted into other Cover Tennessee programs that provide drug coverage (Pinto, Tennessean, 2/22).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Louisiana reclassifies drugs used in abortions as controlled dangerous substances